• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

c-Met受体酪氨酸激酶的寡聚化诱导差异性去磷酸化

Oligomerization-induced differential dephosphorylation of c-Met receptor tyrosine kinase.

作者信息

Sheth Payal R, Watowich Stanley J

机构信息

Department of Human Biological Chemistry and Genetics and Sealy Center for Structural Biology, University of Texas Medical Branch, Galveston, Texas 77555-0645, USA.

出版信息

Biochemistry. 2005 Aug 23;44(33):10984-93. doi: 10.1021/bi050855u.

DOI:10.1021/bi050855u
PMID:16101282
Abstract

Although protein tyrosine phosphatases (PTPs) are significant negative regulators of receptor tyrosine kinase (RTK)-initiated cell signaling, it is unknown how RTK oligomerization modulates the equilibrium established between kinase and phosphatase activity. To determine the impact of oligomerization on the ability of c-MET RTK to undergo dephosphorylation, we examined the relative dephosphorylation kinetics of similarly phosphorylated dimeric TPR-MET and monomeric cytoMET. Notably, we observed that the dephosphorylation kinetics of phosphorylated MET were significantly modulated by its oligomeric state, with the global dephosphorylation rate of TPR-MET severalfold slower than the dephosphorylation rate of monomeric cytoMET. Furthermore, there were important site-specific differences in the dephosphorylation patterns of cytoMET and TPR-MET. Reduced dephosphorylation activity was predicted to eliminate or reduce the requirement of ligand-dependent oligomerization for MET autophosphorylation. This was demonstrated by the rapid phosphorylation of unstimulated c-MET on its activation loop and carboxy-terminal tyrosines following pervanadate treatment of cells expressing c-MET. We conclude that the MET oligomerization state is a critical regulator of its dephosphorylation rate. Thus, oligomerization plays a role in modifying the receptor's kinase and dephosphorylation rates to change the equilibrium levels of phosphorylated and dephosphorylated receptor in response to ligand stimulation, and that this may be a general mechanism utilized by many oligomeric receptor tyrosine kinases for regulation of their activity.

摘要

尽管蛋白酪氨酸磷酸酶(PTPs)是受体酪氨酸激酶(RTK)启动的细胞信号传导的重要负调节因子,但尚不清楚RTK寡聚化如何调节激酶和磷酸酶活性之间建立的平衡。为了确定寡聚化对c-MET RTK去磷酸化能力的影响,我们检测了相似磷酸化的二聚体TPR-MET和单体细胞MET(cytoMET)的相对去磷酸化动力学。值得注意的是,我们观察到磷酸化MET的去磷酸化动力学受到其寡聚状态的显著调节,TPR-MET的整体去磷酸化速率比单体cytoMET的去磷酸化速率慢几倍。此外,cytoMET和TPR-MET的去磷酸化模式存在重要的位点特异性差异。去磷酸化活性降低预计会消除或减少MET自磷酸化对配体依赖性寡聚化的需求。在用过氧钒酸盐处理表达c-MET的细胞后,未受刺激的c-MET在其激活环和羧基末端酪氨酸上的快速磷酸化证明了这一点。我们得出结论,MET寡聚状态是其去磷酸化速率的关键调节因子。因此,寡聚化在改变受体的激酶和去磷酸化速率以响应配体刺激改变磷酸化和去磷酸化受体的平衡水平方面发挥作用,并且这可能是许多寡聚受体酪氨酸激酶用于调节其活性的普遍机制。

相似文献

1
Oligomerization-induced differential dephosphorylation of c-Met receptor tyrosine kinase.c-Met受体酪氨酸激酶的寡聚化诱导差异性去磷酸化
Biochemistry. 2005 Aug 23;44(33):10984-93. doi: 10.1021/bi050855u.
2
Identification of tyrosine 489 in the carboxy terminus of the Tpr-Met oncoprotein as a major site of autophosphorylation.鉴定Tpr-Met癌蛋白羧基末端的酪氨酸489为自磷酸化的主要位点。
Biochemistry. 1996 Jan 23;35(3):1010-7. doi: 10.1021/bi9514065.
3
Regulation of the wild-type and Y1235D mutant Met kinase activation.野生型和Y1235D突变型Met激酶激活的调控。
Biochemistry. 2005 Nov 1;44(43):14110-9. doi: 10.1021/bi051242k.
4
Oligomerization-dependent changes in the thermodynamic properties of the TPR-MET receptor tyrosine kinase.TPR-MET受体酪氨酸激酶热力学性质中依赖寡聚化的变化
Biochemistry. 2004 Aug 17;43(32):10570-8. doi: 10.1021/bi0363275.
5
Enzymatic characterization of c-Met receptor tyrosine kinase oncogenic mutants and kinetic studies with aminopyridine and triazolopyrazine inhibitors.c-Met受体酪氨酸激酶致癌突变体的酶学特性及与氨基吡啶和三唑并吡嗪抑制剂的动力学研究。
Biochemistry. 2009 Jun 16;48(23):5339-49. doi: 10.1021/bi900438w.
6
Oligomerization-induced modulation of TPR-MET tyrosine kinase activity.
J Biol Chem. 2003 Jul 25;278(30):27456-63. doi: 10.1074/jbc.M210648200. Epub 2003 Apr 23.
7
Tyrosine phosphorylation of p145met mediated by EGFR and Src is required for serum-independent survival of human bladder carcinoma cells.表皮生长因子受体(EGFR)和Src介导的p145met酪氨酸磷酸化是人类膀胱癌细胞不依赖血清存活所必需的。
J Cell Sci. 2006 Nov 15;119(Pt 22):4623-33. doi: 10.1242/jcs.03236. Epub 2006 Oct 24.
8
Tetraspanin KAI1/CD82 suppresses invasion by inhibiting integrin-dependent crosstalk with c-Met receptor and Src kinases.四跨膜蛋白KAI1/CD82通过抑制与c-Met受体和Src激酶的整合素依赖性串扰来抑制侵袭。
Oncogene. 2006 Apr 13;25(16):2367-78. doi: 10.1038/sj.onc.1209269.
9
Oncogenic activation of the Met receptor tyrosine kinase fusion protein, Tpr-Met, involves exclusion from the endocytic degradative pathway.Met受体酪氨酸激酶融合蛋白Tpr-Met的致癌激活涉及从内吞降解途径中排除。
Oncogene. 2007 Nov 8;26(51):7213-21. doi: 10.1038/sj.onc.1210522. Epub 2007 May 28.
10
Inhibition of Abl tyrosine kinase enhances nerve growth factor-mediated signaling in Bcr-Abl transformed cells via the alteration of signaling complex and the receptor turnover.抑制Abl酪氨酸激酶可通过改变信号复合物和受体周转来增强神经生长因子介导的Bcr-Abl转化细胞中的信号传导。
Oncogene. 2008 Aug 7;27(34):4678-89. doi: 10.1038/onc.2008.107. Epub 2008 Apr 21.

引用本文的文献

1
LRRK2 in Parkinson's disease: function in cells and neurodegeneration.LRRK2 在帕金森病中的作用:细胞与神经退行性变。
FEBS J. 2009 Nov;276(22):6436-44. doi: 10.1111/j.1742-4658.2009.07342.x. Epub 2009 Oct 5.
2
Biochemical basis for the functional switch that regulates hepatocyte growth factor receptor tyrosine kinase activation.调节肝细胞生长因子受体酪氨酸激酶激活的功能开关的生化基础。
Biochemistry. 2008 Apr 1;47(13):4028-38. doi: 10.1021/bi701892f. Epub 2008 Mar 7.